Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001411690-26-000021
Filing Date
2026-05-08
Accepted
2026-05-08 16:02:35
Documents
17

Document Format Files

Seq Description Document Type Size
1 S-3 bngo-20260508.htm S-3 614366
2 EX-4.18 bngo-ex4_18.htm EX-4.18 563324
3 EX-4.19 bngo-ex4_19.htm EX-4.19 648869
4 EX-5.1 bngo-ex5_1.htm EX-5.1 52750
5 EX-23.1 bngo-ex23_1.htm EX-23.1 5421
6 EX-FILING FEES bngo-exfiling_fees.htm   iXBRL EX-FILING FEES 48988
7 GRAPHIC img209773627_0.jpg GRAPHIC 18487
8 GRAPHIC img209773627_1.jpg GRAPHIC 23869
  Complete submission text file 0001411690-26-000021.txt   2164130

Data Files

Seq Description Document Type Size
20 EXTRACTED XBRL INSTANCE DOCUMENT bngo-exfiling_fees_htm.xml XML 16808
Mailing Address 9540 TOWNE CENTRE DRIVE SUITE 100 SAN DIEGO CA 92121
Business Address 9540 TOWNE CENTRE DRIVE SUITE 100 SAN DIEGO CA 92121 (858) 888-7600
Bionano Genomics, Inc. (Filer) CIK: 0001411690 (see all company filings)

EIN.: 261756290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-295699 | Film No.: 26958139
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)